{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:42:13Z","timestamp":1787776933152,"version":"build-2784847793"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T00:00:00Z","timestamp":1485129600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s12022-017-9469-4","type":"journal-article","created":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T04:24:16Z","timestamp":1485145456000},"page":"75-82","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A Somatic HIF2\u03b1 Mutation-Induced Multiple and Recurrent Pheochromocytoma\/Paraganglioma with Polycythemia: Clinical Study with Literature Review"],"prefix":"10.1007","volume":"28","author":[{"given":"Qiuli","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dali","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaolei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianzheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,23]]},"reference":[{"issue":"5","key":"9469_CR1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1055\/s-0031-1301302","volume":"44","author":"AP Gimenez-Roqueplo","year":"2012","unstructured":"Gimenez-Roqueplo, A.P., P.L. Dahia and M. Robledo, An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Horm Metab Res, 2012. 44(5): p. 328\u201333.","journal-title":"Horm Metab Res"},{"issue":"3","key":"9469_CR2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MED.0b013e32835fcc45","volume":"20","author":"A Vicha","year":"2013","unstructured":"Vicha, A., Z. Musil and K. Pacak, Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options. Curr Opin Endocrinol Diabetes Obes, 2013. 20(3): p. 186\u201391.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"20","key":"9469_CR3","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1093\/hmg\/ddr324","volume":"20","author":"N Burnichon","year":"2011","unstructured":"Burnichon, N., Vescovo, L., Amar, L., Libe, R., de Reynies, A., Venisse, A., Jouanno, E., Laurendeau, I., Parfait, B., Bertherat, J., Plouin, P.F., Jeunemaitre, X., Favier, J., Gimenez-Roqueplo, A.P. Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma. Hum Mol Genet, 2011. 20(20): p. 3974\u201385.","journal-title":"Hum Mol Genet"},{"issue":"26","key":"9469_CR4","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1093\/hmg\/dds402","volume":"21","author":"J Welander","year":"2012","unstructured":"Welander, J.,Larsson, C., Backdahl, M., Hareni, N., Sivler, T., Brauckhoff, M., Soderkvist, P., Gimm, O., Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas. Hum Mol Genet, 2012. 21(26): p. 5406\u201316.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"9469_CR5","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1182\/blood-2007-07-101576","volume":"111","author":"D Pietra","year":"2008","unstructured":"Pietra, D.,Li, S., Brisci, A., Passamonti, F., Rumi, E., Theocharides, A., Ferrari, M., Gisslinger, H., Kralovics, R., Cremonesi, L., Skoda, R., Cazzola, M., Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders. Blood, 2008. 111(3): p. 1686\u20139.","journal-title":"Blood"},{"issue":"13","key":"9469_CR6","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1056\/NEJMc090088","volume":"360","author":"HK Eltzschig","year":"2009","unstructured":"Eltzschig, H.K., T. Eckle and A. Grenz, PHD2 mutation and congenital erythrocytosis with paraganglioma. N Engl J Med, 2009. 360(13): p. 1361\u20132; author reply 1362.","journal-title":"N Engl J Med"},{"issue":"10","key":"9469_CR7","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1056\/NEJMoa1205119","volume":"367","author":"Z Zhuang","year":"2012","unstructured":"Zhuang, Z.,Yang, C., Lorenzo, F., Merino, M., Fojo, T., Kebebew, E., Popovic, V., Stratakis, C.A., Prchal, J.T., Pacak, K., Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia. N Engl J Med, 2012. 367(10): p. 922\u201330.","journal-title":"N Engl J Med"},{"issue":"3","key":"9469_CR8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/ERC-13-0530","volume":"21","author":"N Kimura","year":"2014","unstructured":"Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T, Ito S, Kimura I, Naruse M, Phaeochromocytoma Study Group in J. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocrine-related cancer. 2014;21(3):405\u2013414.","journal-title":"Endocrine-related cancer."},{"issue":"1","key":"9469_CR9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF01607135","volume":"421","author":"N Kimura","year":"1992","unstructured":"Kimura N, Miura Y, Nagatsu I, Nagura H. Catecholamine synthesizing enzymes in 70 cases of functioning and non-functioning phaeochromocytoma and extra-adrenal paraganglioma. Virchows Archiv A, Pathological anatomy and histopathology. 1992;421(1):25\u201332.","journal-title":"Virchows Archiv A, Pathological anatomy and histopathology."},{"issue":"1","key":"9469_CR10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1385\/EP:16:1:023","volume":"16","author":"N Kimura","year":"2005","unstructured":"Kimura N, Watanabe T, Noshiro T, Shizawa S, Miura Y. Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors. Endocrine pathology. 2005;16(1):23\u201332.","journal-title":"Endocrine pathology."},{"issue":"1","key":"9469_CR11","doi-asserted-by":"crossref","first-page":"e86756","DOI":"10.1371\/journal.pone.0086756","volume":"9","author":"J Crona","year":"2014","unstructured":"Crona, J.,Nordling, M., Maharjan, R., Granberg, D., Stalberg, P., Hellman, P., Bjorklund, P., Integrative genetic characterization and phenotype correlations in pheochromocytoma and paraganglioma tumours. PLoS One, 2014. 9(1): p. e86756.","journal-title":"PLoS One"},{"key":"9469_CR12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3181\/00379727-108-26957","volume":"108","author":"TA WALDMANN","year":"1961","unstructured":"WALDMANN, T.A. and J.E. BRADLEY, Polycythemia secondary to a pheochromocytoma with production of an erythropoiesis stimulating factor by the tumor. Proc Soc Exp Biol Med, 1961. 108: p. 425\u20137.","journal-title":"Proc Soc Exp Biol Med"},{"issue":"1","key":"9469_CR13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2169\/internalmedicine.40.38","volume":"40","author":"Y Karasawa","year":"2001","unstructured":"Karasawa, Y., Sakaguchi, M., Minami, S., Kitano, K., Kawa, S., Aoki, Y., Itoh, N., Sakurai, A., Miyazaki, M., Watanabe, T., Akimoto, M., Arakura, N., Kiyosawa, K., Duodenal somatostatinoma and erythrocytosis in a patient with von Hippel-Lindau disease type 2A. Intern Med, 2001. 40(1): p. 38\u201343.","journal-title":"Intern Med"},{"issue":"25","key":"9469_CR14","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1056\/NEJMoa0806277","volume":"359","author":"C Ladroue","year":"2008","unstructured":"Ladroue, C.,Carcenac, R., Leporrier, M., Gad, S., Le Hello, C., Galateau-Salle, F., Feunteun, J., Pouyssegur, J., Richard, S., Gardie, B., PHD2 mutation and congenital erythrocytosis with paraganglioma. N Engl J Med, 2008. 359(25): p. 2685\u201392.","journal-title":"N Engl J Med"},{"issue":"1","key":"9469_CR15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00109-014-1205-7","volume":"93","author":"C Yang","year":"2015","unstructured":"Yang, C., Zhuang, Z., Fliedner, S M., Shankavaram, U., Sun, M G., Bullova, P., Zhu, R., Elkahloun, A G., Kourlas, P J., Merino, M., Kebebew, E., Pacak, K., Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma\/paraganglioma-polycythemia. J Mol Med (Berl), 2015. 93(1): 93\u2013104.","journal-title":"J Mol Med (Berl)"},{"issue":"4","key":"9469_CR16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00109-012-0967-z","volume":"91","author":"FR Lorenzo","year":"2013","unstructured":"Lorenzo, F.R., Yang, C., Ng Tang Fui M., Vankayalapati, H., Zhuang, Z., Huynh, T., Grossmann, M., Pacak, K., Prchal, J T., A novel EPAS1\/HIF2A germline mutation in a congenital polycythemia with paraganglioma. J Mol Med (Berl), 2013. 91(4): p. 507\u201312.","journal-title":"J Mol Med (Berl)"},{"issue":"13","key":"9469_CR17","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1200\/JCO.2012.47.1912","volume":"31","author":"K Pacak","year":"2013","unstructured":"Pacak, K., Jochmanova, I., Prodanov, T., Yang, C., Merino, M J., Fojo, T., Prchal, J T., Tischler, A S., Lechan, R M., Zhuang, Z., New syndrome of paraganglioma and somatostatinoma associated with polycythemia. J Clin Oncol, 2013. 31(13): p. 1690\u20138.","journal-title":"J Clin Oncol"},{"issue":"11","key":"9469_CR18","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/hmg\/ddt069","volume":"22","author":"I Comino-Mendez","year":"2013","unstructured":"Comino-Mendez, I., de Cubas, A A., Bernal, C., Alvarez-Escola, C., Sanchez-Malo, C., Ramirez-Tortosa, C L., Pedrinaci, S., Rapizzi, E., Ercolino, T., Bernini, G., Bacca, A., Leton, R., Pita, G., Alonso, M R., Leandro-Garcia, L J., Gomez-Grana, A., Inglada-Perez, L., Mancikova, V., Rodriguez-Antona, C., Mannelli, M., Robledo, M., Cascon, A., Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis. Hum Mol Genet, 2013. 22(11): p. 2169\u201376.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"9469_CR19","doi-asserted-by":"crossref","first-page":"E369","DOI":"10.1210\/jc.2013-2600","volume":"99","author":"A Buffet","year":"2014","unstructured":"Buffet, A.,Smati, S., Mansuy, L., Menara, M., Lebras, M., Heymann, M.F., Simian, C., Favier, J., Murat, A., Cariou, B., Gimenez-Roqueplo, A.P., Mosaicism in HIF2A-related polycythemia-paraganglioma syndrome. J Clin Endocrinol Metab, 2014. 99(2): p. E369\u201373.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"9469_CR20","doi-asserted-by":"crossref","first-page":"e1787","DOI":"10.1542\/peds.2013-2419","volume":"133","author":"H Toyoda","year":"2014","unstructured":"Toyoda, H., Hirayama, J., Sugimoto, Y., Uchida, K., Ohishi, K., Hirayama, M., Komada, Y., Polycythemia and paraganglioma with a novel somatic HIF2A mutation in a male. Pediatrics, 2014. 133(6): p. e1787\u201391.","journal-title":"Pediatrics"},{"issue":"22","key":"9469_CR21","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1056\/NEJMc1211953","volume":"367","author":"J Favier","year":"2012","unstructured":"Favier, J., A. Buffet and A.P. Gimenez-Roqueplo, HIF2A mutations in paraganglioma with polycythemia. N Engl J Med, 2012. 367(22): p. 2161; author reply 2161-2.","journal-title":"N Engl J Med"},{"issue":"5","key":"9469_CR22","doi-asserted-by":"crossref","first-page":"E908","DOI":"10.1210\/jc.2013-1217","volume":"98","author":"D Taieb","year":"2013","unstructured":"Taieb, D.,Yang, C., Delenne, B., Zhuang, Z., Barlier, A., Sebag, F., Pacak, K., First report of bilateral pheochromocytoma in the clinical spectrum of HIF2A-related polycythemia-paraganglioma syndrome. J Clin Endocrinol Metab, 2013. 98(5): p. E908\u201313.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9469_CR23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10059-010-0067-2","volume":"29","author":"A Loboda","year":"2010","unstructured":"Loboda, A., A. Jozkowicz and J. Dulak, HIF-1 and HIF-2 transcription factors\u2014similar but not identical. Mol Cells, 2010. 29(5): p. 435\u201342.","journal-title":"Mol Cells"},{"issue":"Suppl 2","key":"9469_CR24","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.33549\/physiolres.932789","volume":"63","author":"I Jochmanova","year":"2014","unstructured":"Jochmanova, I.,Zelinka, T., Widimsky, J Jr., Pacak, K., HIF signaling pathway in pheochromocytoma and other neuroendocrine tumors. Physiol Res, 2014. 63 Suppl 2: p. S251\u201362.","journal-title":"Physiol Res"},{"issue":"17","key":"9469_CR25","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/jnci\/djt201","volume":"105","author":"I Jochmanova","year":"2013","unstructured":"Jochmanova, I., Yang, C., Zhuang, Z., Pacak, K., Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction. J Natl Cancer Inst, 2013. 105(17): p. 1270\u201383.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"9469_CR26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1530\/ERC-13-0101","volume":"20","author":"RA Toledo","year":"2013","unstructured":"Toledo, R.A., Qin, Y., Srikantan, S., Morales, N P., Li, Q., Deng, Y., Kim, S W., Pereira, M A., Toledo, S P., Su, X., Aguiar, R C., Dahia, P L., In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas. Endocr Relat Cancer, 2013. 20(3): p. 349\u201359.","journal-title":"Endocr Relat Cancer"},{"issue":"10","key":"9469_CR27","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3324\/haematol.2013.088369","volume":"98","author":"S Perrotta","year":"2013","unstructured":"Perrotta, S., Stiehl, D P., Punzo, F., Scianguetta, S., Borriello, A., Bencivenga, D., Casale, M., Nobili, B., Fasoli, S., Balduzzi, A., Cro, L., Nytko, K J., Wenger, R H., Della, Ragione F., Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in the normal range. Haematologica, 2013. 98(10): p. 1624\u201332.","journal-title":"Haematologica"},{"issue":"11","key":"9469_CR28","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1182\/blood-2008-02-137703","volume":"111","author":"MJ Percy","year":"2008","unstructured":"Percy, M.J., Beer, P A., Campbell, G., Dekker, A W., Green, A R., Oscier, D., Rainey, M G., van Wijk, R., Wood, M., Lappin, T R., McMullin, M F., Lee, F S., Novel exon 12 mutations in the HIF2A gene associated with erythrocytosis. Blood, 2008. 111(11): p. 5400\u20132.","journal-title":"Blood"},{"issue":"24","key":"9469_CR29","doi-asserted-by":"crossref","first-page":"17134","DOI":"10.1074\/jbc.M112.444059","volume":"288","author":"Q Tan","year":"2013","unstructured":"Tan, Q., Kerestes, H., Percy, M J., Pietrofesa, R., Chen, L., Khurana, T S., Christofidou-Solomidou, M., Lappin, T R., Lee, F S., Erythrocytosis and pulmonary hypertension in a mouse model of human HIF2A gain of function mutation. J Biol Chem, 2013. 288(24): p. 17134\u201344.","journal-title":"J Biol Chem"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-017-9469-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-017-9469-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-017-9469-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T08:54:40Z","timestamp":1601369680000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-017-9469-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,23]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["9469"],"URL":"https:\/\/doi.org\/10.1007\/s12022-017-9469-4","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,23]]}}}